Harbour Investments’s Zevra Therapeutics ZVRA Stock Holding History

Harbour Investments’s Portfolio ZVRA Stock Details ZVRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-168	Closed	-$1.1K	–	3322
2023 Q4	$1.1K	Hold	168	–	–	﹤0.01%	2805
2023 Q3	$810	Hold	168	–	–	﹤0.01%	2737
2023 Q2	$857	Hold	168	–	–	﹤0.01%	2720
2023 Q1	$924	Hold	168	–	–	﹤0.01%	2702
2022 Q4	$771	Hold	168	–	–	﹤0.01%	2731
2022 Q3	$1K	Hold	168	–	–	﹤0.01%	2680
2022 Q2	$1K	Buy	+168	New	+$766	﹤0.01%	2680
2021 Q4	$1K	Hold	168	–	–	﹤0.01%	2577
2021 Q3	$2K	Hold	168	–	–	﹤0.01%	3386
2021 Q2	$2K	Hold	168	–	–	﹤0.01%	3448
2021 Q1	$2K	Buy	+168	New	+$1.47K	﹤0.01%	3286

Other funds holding ZVRA

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Janney Montgomery Scott Philadelphia, Pennsylvania $51.6B AUM 27.34% 1-Year Est. Return

RPCONE

Retirement Planning Company of New England Warwick, Rhode Island $278M AUM 38.65% 1-Year Est. Return

ACM

Altium Capital Management New York $47.5M AUM 115.72% 1-Year Est. Return

Harbour Investments's ZVRA Position: Q1 2024 in Review

Harbour Investments sold out of Zevra Therapeutics (ZVRA) in Q1 2024, closing a stake of 168 shares — an estimated $1.1K sold.

Harbour Investments first reported a position in ZVRA in Q1 2021 and held it in 11 quarters. The position peaked at $2K in Q3 2021. 89 funds tracked by Wall St. Rank hold ZVRA as of Q1 2024.

Harbour Investments reported no remaining Zevra Therapeutics position as of Q1 2024 after selling out during the quarter.
Harbour Investments sold 168 Zevra Therapeutics shares in Q1 2024, an estimated $1.1K.
Harbour Investments first reported a position in Zevra Therapeutics in Q1 2021 and held it in 11 quarters.
Harbour Investments's Zevra Therapeutics position peaked at $2K in Q3 2021.
89 funds tracked by Wall St. Rank held Zevra Therapeutics as of Q1 2024.

Based on Harbour Investments's 13F filing for Q1 2024, filed 22 Jul 2024.